Skip to main content

and
  1. Article

    Open Access

    Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans

    Orexin neurons originating in the perifornical and lateral hypothalamic area project to anxiety- and panic-associated neural circuitry, and are highly reactive to anxiogenic stimuli. Preclinical evidence sugge...

    Giacomo Salvadore, Pascal Bonaventure, Anantha Shekhar in Translational Psychiatry (2020)

  2. No Access

    Article

    Default mode network connectivity change corresponds to ketamine’s delayed glutamatergic effects

    Ketamine exerts rapid antidepressant effects peaking 24 h after a single infusion, which have been suggested to be reflected by both reduced functional connectivity (FC) within default mode network (DMN) and a...

    Meng Li, Marie Woelfer, Lejla Colic in European Archives of Psychiatry and Clinic… (2020)

  3. No Access

    Article

    Validation of a novel Montreal Cognitive Assessment scoring algorithm in non-demented Parkinson’s disease patients

    The early diagnosis of mild cognitive impairment (PD-MCI) in Parkinson’s disease (PD) is essential as it increases the future risk for PD dementia (PDD). Recently, a novel weighting algorithm for the Montreal ...

    Patricia Sulzer, Sara Becker, Walter Maetzler, Elke Kalbe in Journal of Neurology (2018)

  4. Article

    Open Access

    PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects

    Inflammation is associated with major depressive disorder (MDD). Translocator protein 18 kDa (TSPO), a putative biomarker of neuroinflammation, is quantified using positron emission tomography (PET) and 11C-PBR28...

    Erica M. Richards, Paolo Zanotti-Fregonara, Masahiro Fujita in EJNMMI Research (2018)

  5. Article

    Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities

    The anterior cingulate cortex (ACC) has shown decreased glutamate levels in patients with major depressive disorder. Subanesthetic doses of ketamine were repeatedly shown to improve depressive symptoms within ...

    Meng Li, Liliana Ramona Demenescu, Lejla Colic in Neuropsychopharmacology (2017)

  6. Article

    Open Access

    Sirukumab: A Potential Treatment for Mood Disorders?

    Convergent evidence indicates that abnormalities in the innate immune system may be pertinent to the pathogenesis, phenomenology, and possible treatment of several mental disorders. In kee** with this view, ...

    Aileen J. Zhou, Yena Lee, Giacomo Salvadore, Benjamin Hsu in Advances in Therapy (2017)

  7. Article

    Bcl-2 rs956572 Polymorphism is Associated with Increased Anterior Cingulate Cortical Glutamate in Euthymic Bipolar I Disorder

    B-cell lymphoma 2 (Bcl-2) is an important regulator of cellular plasticity and resilience. In bipolar disorder (BD), studies have shown a key role for a Bcl-2 gene single-nucleotide polymorphism (SNP) rs956572 in...

    Márcio Gerhardt Soeiro-de-Souza, Giacomo Salvadore in Neuropsychopharmacology (2013)

  8. Article

    Anterior Cingulate Desynchronization and Functional Connectivity with the Amygdala During a Working Memory Task Predict Rapid Antidepressant Response to Ketamine

    Pregenual anterior cingulate cortex (pgACC) hyperactivity differentiates treatment responders from non-responders to various pharmacological antidepressant interventions, including ketamine, an N-methyl-D-asparta...

    Giacomo Salvadore, Brian R Cornwell, Fabio Sambataro in Neuropsychopharmacology (2010)

  9. No Access

    Chapter

    Neuroprotective Agents in Mood Disorders: Pathophysiological and Therapeutic Implications

    Drug development for mood disorders such as major depressive disorder (MDD) and bipolar disorder (BPD) has undergone an important paradigm shift in the last decade due to our expanding knowledge of the pathoph...

    Giacomo Salvadore, Rodrigo Machado-Vieira in Brain Protection in Schizophrenia, Mood an… (2010)